OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-AKR1C3 antibodies

Anti-AKR1C3 Antibody

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA310144 Rabbit anti-AKR1C3 polyclonal antibody 100ul $325 3 Weeks
LC418464 AKR1C3 HEK293T cell transient overexpression lysate (as WB positive control) 20ug $50 In Stock

Buy any antibody of 100ul or more, get a free package of 3 loading control antibody samples. View Details Add to Shopping Cart

spacer
WB(1)
IF(1)
spacer
Also for AKR1C3 (NM_003739)
cDNA Clone shRNA/siRNA CRISPR KO Kit Protein Antibody

OriGene Data

ImmunogenSynthetic peptide conjugated to KLH
Clone Name IsotypeRabbit IgG
Species ReactivityHuman Concentration1ug/ul
Guaranteed Application *WB, IF Suggested DilutionsWB: 1:500, IF: 1:50
BufferPBS, pH 7.4 with 0.05% sodium azide.
Purification Protein A purified

Reference Data

Target NameHomo sapiens aldo-keto reductase family 1, member C3 (AKR1C3), transcript variant 1
Alternative NameDD3; DDX; HA1753; HAKRB; HAKRe; hluPGFS; HSD17B5; PGFS
Database LinkNP_003730
Entrez Gene 8644 Human
Function
Related PathwayDruggable Genome Arachidonic acid metabolismMetabolism of xenobiotics by cytochrome P450

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

Western blot analysis of MCF-7 and fetal liver lysates with anti-AKR1C3 antibody (1:500). This antibody identified a band of ~37kDa in MCF-7 and fetal liver lysates.
spacer
Immunofluorescence staining of HeLa cells using anti-AKR1C3 antibody (1:50).
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title